Profile data is unavailable for this security.
About the company
A1M Pharma AB is a Sweden-based company, which is active within the healthcare sector. The Company conducts development and commercialization of treatment and diagnostics based on the alpha-1-microglobulin (A1M) protein. The protein serves as a radical inhibitor, an antioxidant, a protector against free hemoglobin and a tissue repairer. A1M is a candidate for different therapeutic and diagnostic uses, such as alleviation of autoimmune diseases and stroke treatment. The Company works with the protein and conducts research at the Biomedical Center in Lund University, Sweden. The Company develops a drug for intravenous treatment of preeclampsia, a condition that can occur during pregnancy and can contribute to premature deliveries.
- Revenue in SEK (TTM)0.00
- Net income in SEK-78.82m
- Incorporated2008
- Employees6.00
- LocationGuard Therapeutics International AB (publ)Guard Therapeutics, Nybrogatan 34, 2 trSTOCKHOLM 114 39SwedenSWE
- Phone+46 86706551
- Websitehttps://guardtherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annexin Pharmaceuticals AB (publ) | 0.00 | -52.36m | 291.01m | 4.00 | -- | 8.08 | -- | -- | -0.1873 | -0.1873 | 0.00 | 0.0676 | 0.00 | -- | -- | 0.00 | -162.59 | -125.42 | -220.41 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Abliva AB | 137.00k | -102.13m | 295.62m | 6.00 | -- | 2.87 | -- | 2,157.81 | -0.0928 | -0.0928 | 0.0001 | 0.0638 | 0.0013 | -- | 0.0062 | -- | -93.81 | -74.59 | -103.87 | -86.98 | -35,826.28 | -- | -74,542.34 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| Lifecare ASA | 15.62m | -50.28m | 322.26m | 32.00 | -- | 2.69 | -- | 20.63 | -0.3152 | -0.3152 | 0.0999 | 0.632 | 0.1564 | -- | -- | 502,995.00 | -50.29 | -40.00 | -56.16 | -45.26 | -- | -- | -321.48 | -175.53 | -- | -- | 0.0918 | -- | -40.88 | 30.29 | -101.74 | -- | -- | -- |
| Curasight A/S | -43.29m | -48.36m | 337.53m | 4.00 | -- | 17.48 | -- | -- | -1.51 | -1.51 | -1.35 | 0.6008 | -0.7563 | -- | -- | -7,107,500.00 | -84.49 | -24.61 | -111.31 | -26.01 | -- | -- | -- | -- | -- | -32.26 | 0.4439 | -- | -123.97 | -- | -42.62 | -- | -- | -- |
| Alzinova AB | 300.00k | -18.12m | 340.61m | 5.00 | -- | 2.02 | -- | 1,135.37 | -0.332 | -0.332 | 0.0055 | 1.89 | 0.0025 | -- | 0.4752 | 60,000.00 | -15.15 | -10.77 | -15.91 | -11.27 | -2,621.00 | -- | -6,039.67 | -18,447.90 | -- | -392.89 | 0.0076 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
| Herantis Pharma Oyj | 0.00 | -6.95m | 342.29m | 10.00 | -- | 14.77 | 14.53 | -- | -0.0146 | -0.0146 | 0.00 | 0.1012 | 0.00 | -- | -- | 0.00 | -13.93 | -80.46 | -27.32 | -104.37 | -- | -- | -- | -- | -- | -- | 0.0145 | -- | -- | -- | 103.00 | -- | -- | -- |
| Medivir AB | 6.83m | -105.92m | 367.91m | 10.00 | -- | 2.09 | -- | 53.84 | -1.45 | -1.45 | 0.0824 | 1.57 | 0.0311 | -- | 1.12 | 683,300.00 | -48.26 | -28.91 | -61.14 | -34.77 | -1,152.23 | -467.42 | -1,550.15 | -675.96 | -- | -- | 0.0543 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
| Lytix Biopharma AS | -97.07bn | -97.07bn | 379.48m | 10.00 | -- | 6.60 | -- | -- | -- | -- | -- | 1.19 | -- | -- | -- | -- | -- | -56.91 | -- | -65.83 | -- | -- | -- | -771.78 | -- | -- | 0.0482 | -- | -63.82 | 63.94 | -56.77 | -- | -- | -- |
| Initiator Pharma A/S | 0.00 | -25.73m | 386.53m | 3.00 | -- | 14.24 | -- | -- | -0.4688 | -0.4688 | 0.00 | 0.513 | 0.00 | -- | -- | 0.00 | -65.39 | -68.27 | -73.28 | -74.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 27.95 | -- | -- | -- |
| Bergenbio ASA | 505.74k | -150.85m | 392.70m | 15.00 | -- | 2.31 | -- | 776.49 | -5.37 | -5.37 | 0.018 | 4.48 | 0.0023 | -- | 0.0411 | 20,840.00 | -67.73 | -66.15 | -85.55 | -78.74 | -- | -- | -29,828.21 | -11,419.44 | -- | -- | 0.00 | -- | -9.00 | -31.43 | 36.98 | -- | -- | -- |
| SynAct Pharma AB | 0.00 | -165.96m | 408.84m | 5.00 | -- | 2.19 | -- | -- | -4.75 | -4.75 | 0.00 | 4.53 | 0.00 | -- | -- | 0.00 | -61.52 | -125.17 | -67.60 | -151.70 | -- | -- | -- | -- | -- | -231.85 | 0.0076 | -- | -- | -- | -117.54 | -- | -- | -- |
| Mendus AB (publ) | 0.00 | -141.42m | 412.29m | 28.00 | -- | 0.5904 | -- | -- | -3.54 | -3.54 | 0.00 | 13.87 | 0.00 | -- | -- | 0.00 | -21.08 | -18.84 | -23.01 | -20.21 | -- | -- | -- | -28,474.53 | -- | -- | 0.0318 | -- | -100.00 | -- | 26.78 | -- | -- | -- |
| Guard Therapeutics Intrntnl AB (publ) | 0.00 | -78.82m | 427.32m | 6.00 | -- | 4.50 | -- | -- | -7.83 | -7.83 | 0.00 | 6.45 | 0.00 | -- | -- | -- | -70.61 | -69.56 | -86.38 | -78.62 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.4289 | -- | -- | -- |
| Hamlet BioPharma AB | 0.00 | -41.82m | 456.12m | 7.00 | -- | -- | -- | -- | -0.2756 | -0.2756 | 0.00 | -- | -- | -- | -- | 0.00 | -- | -80.47 | -- | -97.51 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -104.57 | -- | -- | -- |
| Oncopeptides AB | 21.37m | -262.70m | 457.93m | 67.00 | -- | 2.38 | -- | 21.43 | -1.97 | -1.97 | 0.1604 | 0.9134 | 0.0528 | 0.035 | 0.5727 | 374,894.80 | -64.95 | -141.28 | -83.36 | -200.49 | 99.44 | -- | -1,229.37 | -2,689.06 | 3.44 | -49.51 | 0.4187 | -- | 321.54 | -- | 26.29 | -- | -- | -- |
| Saniona AB | 24.88m | -81.81m | 537.28m | 22.00 | -- | 77.48 | -- | 21.60 | -0.9821 | -0.9821 | 0.2822 | 0.0623 | 0.2386 | -- | 6.23 | 1,081,652.00 | -78.47 | -59.16 | -168.78 | -70.15 | -92.01 | -970.05 | -328.83 | -1,483.55 | -- | -3.03 | 0.8668 | -- | 10.19 | -21.05 | 54.71 | -- | -34.94 | -- |
Data as of Sep 20 2024. Currency figures normalised to Guard Therapeutics International AB (publ)'s reporting currency: Swedish Krona SEK
13.13%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Swedbank Robur Fonder ABas of 30 Aug 2024 | 1.16m | 9.61% |
| Strand Kapitalf�rvaltning ABas of 30 Jun 2024 | 422.69k | 3.51% |
| FCG Fonder ABas of 30 Aug 2024 | 1.73k | 0.01% |
Data from 30 Jun 2024 - 30 Aug 2024Source: FactSet Research Systems Inc.
